[Validity of adjusted morbidity groups with respect to clinical risk groups in the field of primary care].
Validez de los grupos de morbilidad ajustados respecto a los clinical risk groups en el ámbito de la atención primaria.
Age Factors
Bayes Theorem
Cross-Sectional Studies
Diagnosis-Related Groups
/ classification
Emergencies
Family Practice
/ statistics & numerical data
Female
Health Services Needs and Demand
Hospitalization
Humans
Male
Multimorbidity
Nursing
/ statistics & numerical data
Pediatrics
/ statistics & numerical data
Prescription Drugs
/ economics
Primary Health Care
Reproducibility of Results
Risk Factors
Sex Factors
Spain
Agrupador de morbilidad
Atención primaria
Morbidity grouper
Multimorbidity
Multimorbilidad
Primary care
Validez
Validity
Journal
Atencion primaria
ISSN: 1578-1275
Titre abrégé: Aten Primaria
Pays: Spain
ID NLM: 9111075
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
04
05
2017
revised:
19
07
2017
accepted:
18
09
2017
pubmed:
13
2
2018
medline:
16
5
2020
entrez:
14
2
2018
Statut:
ppublish
Résumé
To compare the performance in terms of goodness of fit and explanatory power of 2morbidity groupers in primary care (PC): adjusted morbidity groups (AMG) and clinical risk groups (CRG). Cross-sectional study. PC in the Catalan Institute for the Health (CIH), Catalonia, Spain. Population allocated in primary care centers of the CIH for the year 2014. Three indicators of interest are analyzed such as urgent hospitalization, number of visits and spending in pharmacy. A stratified analysis by centers is applied adjusting generalized lineal models from the variables age, sex and morbidity grouping to explain each one of the 3variables of interest. The statistical measures to analyze the performance of the different models applied are the Akaike index, the Bayes index and the pseudo-variability explained by deviance change. The results show that in the area of the primary care the explanatory power of the AMGs is higher to that offered by the CRGs, especially for the case of the visits and the pharmacy. The performance of GMAs in the area of the CIH PC is higher than that shown by the CRGs.
Identifiants
pubmed: 29433758
pii: S0212-6567(17)30354-2
doi: 10.1016/j.aprim.2017.09.012
pmc: PMC6836969
pii:
doi:
Substances chimiques
Prescription Drugs
0
Types de publication
Comparative Study
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
spa
Sous-ensembles de citation
IM
Pagination
153-161Informations de copyright
Copyright © 2018 The Authors. Publicado por Elsevier España, S.L.U. All rights reserved.
Références
Med Care. 2004 Jan;42(1):81-90
pubmed: 14713742
Lancet. 2012 Jul 7;380(9836):37-43
pubmed: 22579043
J Gen Intern Med. 2007 Apr;22(4):464-9
pubmed: 17372794
J Health Econ. 2014 May;35:109-22
pubmed: 24657375
JAMA. 2012 Jun 20;307(23):2493-4
pubmed: 22797447
Br J Gen Pract. 2011 Jan;61(582):e12-21
pubmed: 21401985
BMJ. 2008 Jul 14;337:a238
pubmed: 18625598
BMC Public Health. 2006 Jun 28;6:171
pubmed: 16805909
Fam Pract. 2013 Apr;30(2):172-8
pubmed: 23045354
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Aten Primaria. 2016 Dec;48(10):674-682
pubmed: 27495004
BMC Health Serv Res. 2008 Mar 04;8:53
pubmed: 18318912
Ann Fam Med. 2012 Mar-Apr;10(2):134-41
pubmed: 22412005
Ann Fam Med. 2005 May-Jun;3(3):223-8
pubmed: 15928225
BMC Med. 2010 Jan 18;8:7
pubmed: 20082689
BMJ. 2007 May 19;334(7602):1016-7
pubmed: 17510108
Br J Gen Pract. 2005 Jul;55(516):529-33
pubmed: 16004738
Ann Fam Med. 2009 Jul-Aug;7(4):357-63
pubmed: 19597174
Arch Intern Med. 2002 Nov 11;162(20):2269-76
pubmed: 12418941